SEEL Annual Revenue
N/A
31 December 2023
Summary:
SEEL annual revenue is not available.SEEL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL Quarterly Revenue
N/A
30 June 2024
Summary:
SEEL quarterly revenue is not available.SEEL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL TTM Revenue
N/A
30 June 2024
Summary:
SEEL TTM revenue is not available.SEEL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
SEEL Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Seelos Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $4.84 M(-47.7%) | $2.63 M(+106.5%) | $4.84 M(+17.5%) |
| Sept 2015 | - | $1.27 M(+175.5%) | $4.12 M(-13.2%) |
| June 2015 | - | $462.00 K(-2.7%) | $4.74 M(-51.3%) |
| Mar 2015 | - | $475.00 K(-75.1%) | $9.73 M(+5.1%) |
| Dec 2014 | $9.26 M(+268.7%) | $1.91 M(+0.5%) | $9.26 M(+20.0%) |
| Sept 2014 | - | $1.90 M(-65.2%) | $7.71 M(+32.0%) |
| June 2014 | - | $5.45 M(+1406.6%) | $5.84 M(+132.7%) |
| Dec 2013 | $2.51 M(-68.4%) | $362.00 K(+1192.9%) | $2.51 M(-44.5%) |
| Sept 2013 | - | $28.00 K(-97.7%) | $4.53 M(-51.8%) |
| June 2013 | - | $1.19 M(+28.3%) | $9.39 M(+14.5%) |
| Mar 2013 | - | $929.00 K(-60.9%) | $8.20 M(+1.8%) |
| Dec 2012 | $7.95 M(+154.6%) | $2.38 M(-51.4%) | $8.06 M(+67.2%) |
| Sept 2012 | - | $4.89 M(>+9900.0%) | $4.82 M(+567.4%) |
| June 2012 | - | $3000.00(-99.6%) | $721.80 K(-68.8%) |
| Mar 2012 | - | $781.00 K(-190.6%) | $2.31 M(-25.8%) |
| Dec 2011 | $3.12 M(-37.3%) | -$861.60 K(-207.8%) | $3.12 M(-37.8%) |
| Sept 2011 | - | $799.40 K(-49.9%) | $5.02 M(-5.5%) |
| June 2011 | - | $1.60 M(+0.5%) | $5.31 M(+2.4%) |
| Mar 2011 | - | $1.59 M(+53.3%) | $5.18 M(+2.8%) |
| Dec 2010 | $4.97 M(+67.2%) | $1.03 M(-5.0%) | $5.04 M(+17.2%) |
| Sept 2010 | - | $1.09 M(-25.9%) | $4.30 M(+29.5%) |
| June 2010 | - | $1.47 M(+1.7%) | $3.32 M(+70.1%) |
| Mar 2010 | - | $1.45 M(+390.4%) | $1.95 M(-34.3%) |
| Dec 2009 | $2.97 M(-50.1%) | $294.80 K(+169.0%) | $2.97 M(-51.9%) |
| Sept 2009 | - | $109.60 K(+6.8%) | $6.18 M(-3.1%) |
| June 2009 | - | $102.60 K(-95.8%) | $6.38 M(-14.7%) |
| Mar 2009 | - | $2.47 M(-29.5%) | $7.47 M(+25.4%) |
| Dec 2008 | $5.96 M(+368.9%) | $3.50 M(+1044.2%) | $5.96 M(+108.2%) |
| Sept 2008 | - | $305.90 K(-74.5%) | $2.86 M(+0.3%) |
| June 2008 | - | $1.20 M(+26.0%) | $2.85 M(+47.3%) |
| Mar 2008 | - | $951.80 K(+135.8%) | $1.94 M(+52.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $1.27 M(-32.0%) | $403.60 K(+36.2%) | $1.27 M(-2.3%) |
| Sept 2007 | - | $296.40 K(+4.6%) | $1.30 M(-10.3%) |
| June 2007 | - | $283.40 K(-1.3%) | $1.45 M(-14.7%) |
| Mar 2007 | - | $287.00 K(-33.7%) | $1.70 M(-8.9%) |
| Dec 2006 | $1.87 M(-22.2%) | $433.10 K(-3.0%) | $1.87 M(-51.2%) |
| Sept 2006 | - | $446.30 K(-16.4%) | $3.83 M(+13.1%) |
| June 2006 | - | $533.70 K(+17.6%) | $3.38 M(+18.6%) |
| Mar 2006 | - | $453.90 K(-81.0%) | $2.85 M(+18.8%) |
| Dec 2005 | $2.40 M(+567.6%) | $2.39 M(>+9900.0%) | $2.40 M(>+9900.0%) |
| Sept 2005 | - | $2500.00(+8.7%) | $9600.00(-86.4%) |
| June 2005 | - | $2300.00(-4.2%) | $70.60 K(-72.6%) |
| Mar 2005 | - | $2400.00(0.0%) | $257.60 K(-28.3%) |
| Dec 2004 | $359.40 K(+224.7%) | $2400.00(-96.2%) | $359.40 K(-10.3%) |
| Sept 2004 | - | $63.50 K(-66.5%) | $400.50 K(-0.3%) |
| June 2004 | - | $189.30 K(+81.7%) | $401.60 K(+88.3%) |
| Mar 2004 | - | $104.20 K(+139.5%) | $213.30 K(+92.5%) |
| Dec 2003 | $110.70 K(-25.2%) | $43.50 K(-32.7%) | $110.80 K(+57.6%) |
| Sept 2003 | - | $64.60 K(+6360.0%) | $70.30 K(-16.2%) |
| June 2003 | - | $1000.00(-41.2%) | $83.90 K(-19.7%) |
| Mar 2003 | - | $1700.00(-43.3%) | $104.50 K(-29.4%) |
| Dec 2002 | $148.00 K(+117.3%) | $3000.00(-96.2%) | $148.10 K(+2.1%) |
| Sept 2002 | - | $78.20 K(+262.0%) | $145.10 K(+116.9%) |
| June 2002 | - | $21.60 K(-52.3%) | $66.90 K(+47.7%) |
| Mar 2002 | - | $45.30 K(>+9900.0%) | $45.30 K(>+9900.0%) |
| Dec 2001 | $68.10 K(>+9900.0%) | - | - |
| Dec 2000 | $0.00(-100.0%) | - | - |
| Sept 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2000 | - | $0.00 | $0.00 |
| Dec 1999 | $1.49 M(-73.9%) | - | - |
| Dec 1998 | $5.71 M(>+9900.0%) | - | - |
| Dec 1997 | $56.20 K | - | - |
FAQ
- What is the all time high annual revenue for Seelos Therapeutics?
- What is the all time high quarterly revenue for Seelos Therapeutics?
- What is the all time high TTM revenue for Seelos Therapeutics?
What is the all time high annual revenue for Seelos Therapeutics?
Seelos Therapeutics all-time high annual revenue is $9.26 M
What is the all time high quarterly revenue for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly revenue is $5.45 M
What is the all time high TTM revenue for Seelos Therapeutics?
Seelos Therapeutics all-time high TTM revenue is $9.73 M